Korean Lawmakers Propose Health Ministry Split Amid MERS Woes
This article was originally published in PharmAsia News
As the impact of the MERS outbreak reverberates throughout South Korea, and amid mounting criticism over how the government - especially the Ministry of Health and Welfare - has handled the crisis situation, lawmakers have proposed a bill to split the ministry in two. This would enable each part to better focus on its specialty and better handle relevant matters, it is claimed.
You may also be interested in...
Faced with the risk of losing their investment from a possible stock delisting amid prosecutors’ probes into company’s management, SillaJen’s individual minority shareholders are demanding the Korea Exchange resume trading of the biotech’s stock, in a rare united move.
Also, deals involving Sumitomo Dainippon, Tolero, Boston Biomedical, Zai Lab, Turning Point, SciClone, EpicentRx, Yuhan, GI Innovation, Takeda, Carmine, HitGen, Morphic, CStone and Burning Rock.
USITC’s initial decision in the Medytox and Daewoong botulinum dispute is favorable to Medytox and poised to take a toll on the Korean firm and partner Evolus as they face a 10-year ban on imports of their product to the US.